RYZ401

· RayzeBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RYZ401, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. [Phase 1]